18 Biggest Mid-Day Losers For Thursday

AEterna Zentaris Inc. (USA) AEZS shares dipped 26.7 percent to $2.67 after the company disclosed that Macrilen failed to achieve its objective in Phase 3 trial. The company is evaluating whether it will continue development of Macrilen.
Kohl's Corporation KSS dropped 18.9 percent to $42.09 after the company lowered its earnings forecast for fiscal 2016. Kohl’s comparable sales dropped 2.1 percent in November and December.
Hebron Technology Co Ltd HEBT shares declined 16 percent to $4.98.
Macy's Inc M dropped 14.3 percent to $30.73 in pre-market trading after the company announced plans to close 68 stores and reduced its FY16 earnings guidance. The company reported November-December sales comps of -2.1 percent.
Castlight Health Inc CSLT tumbled 13 percent to $4.35. Castlight Health reported the purchase of Jiff, Inc. and named John Doyle as CEO of the combined company.
Resources Connection, Inc. RECN dropped 12.2 percent to $17.25 after the company posted downbeat Q2 earnings.
Nordstrom, Inc. JWN shares declined 8.8 percent to $44.62 after rising 2.73 percent on Wednesday.
Mistras Group Inc MG fell 8.7 percent to $24.05 after the company reported weaker-than-expected earnings for its second quarter.
L Brands Inc LB dropped 7.8 percent to $62.07. L Brands reported a 1 percent gain in its net sales for December. The company expects Q4 EPS to be toward lower end of its $1.85-$2.00 guidance.
KNOT Offshore Partners LP KNOP shares declined 7.6 percent to $22.35. KNOT Offshore Partners reported an offering of 2,500,000 common units.
Helix Energy Solutions Group Inc HLX shares fell 7 percent to $9.02. Helix Energy Solutions priced its upsized 23 million share offering at $8.65 per share.
Constellation Brands, Inc. STZ declined 6.2 percent to $148.20. Constellation Brands reported upbeat quarterly profit.
Heron Therapeutics Inc HRTX shares fell 5.4 percent to $13.05. Heron Therapeutics reported topline results from Phase 2 clinical trial of HTX-011 in abdominoplasty. The company also reported synergy of bupivacaine and meloxicam with HTX-011 for the prevention of post-operative pain in Phase 2 clinical studies.
RPM International Inc. RPM dropped 5.3 percent to $51.91 as the company reported weaker-than-expected Q2 earnings.
J C Penney Company Inc JCP shares fell 5.3 percent to $8.02 after rising 1.68 percent on Wednesday.
La-Z-Boy Incorporated LZB dropped 5.2 percent to $30.30. Raymond James downgraded La-Z-Boy from Strong Buy to Market Perform.
Sangamo Biosciences, Inc. SGMO fell 4.3 percent to $3.35. Sangamo Biosciences disclosed that it has received the FDA clearance of investigational New Drug Application for its SB-525 gene therapy program for hemophilia A.
Buffalo Wild Wings BWLD declined around 3 percent to $149.65. Wedbush downgraded Buffalo Wild Wings from Outperform to Neutral.